# Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

> **NCT00520234** · PHASE4 · COMPLETED · sponsor: **Mycoses Study Group** · enrollment: 222 (actual)

## Conditions studied

- Invasive Candidiasis

## Interventions

- **DRUG:** Caspofungin
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00520234
- **Lead sponsor:** Mycoses Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2011-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520234, "Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00520234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*